Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
Eli Lilly and Company
Dana-Farber Cancer Institute
University of California, San Francisco
Eli Lilly and Company
OHSU Knight Cancer Institute
Emory University
H. Lee Moffitt Cancer Center and Research Institute
Wake Forest University Health Sciences
Syros Pharmaceuticals
Novartis
AIDS Malignancy Consortium
Gilead Sciences
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Celgene
Oncology Institute of Southern Switzerland
AstraZeneca
The Netherlands Cancer Institute
University of Chicago
GlaxoSmithKline
AbbVie
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
Nippon Kayaku Co., Ltd.
Piramal Enterprises Limited
National Cancer Institute (NCI)
Mayo Clinic